1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Autologous Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bone Marrow
        1.2.3 Epidermis
    1.3 Market by Application
        1.3.1 Global Autologous Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Neurology
        1.3.3 Orthopedics
        1.3.4 Cancer
        1.3.5 Wound Healing
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Autologous Cell Therapy Market Perspective (2017-2028)
    2.2 Autologous Cell Therapy Growth Trends by Region
        2.2.1 Autologous Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Autologous Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Autologous Cell Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Autologous Cell Therapy Market Dynamics
        2.3.1 Autologous Cell Therapy Industry Trends
        2.3.2 Autologous Cell Therapy Market Drivers
        2.3.3 Autologous Cell Therapy Market Challenges
        2.3.4 Autologous Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Autologous Cell Therapy Players by Revenue
        3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Autologous Cell Therapy Revenue
    3.4 Global Autologous Cell Therapy Market Concentration Ratio
        3.4.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2021
    3.5 Autologous Cell Therapy Key Players Head office and Area Served
    3.6 Key Players Autologous Cell Therapy Product Solution and Service
    3.7 Date of Enter into Autologous Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Cell Therapy Breakdown Data by Type
    4.1 Global Autologous Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Autologous Cell Therapy Breakdown Data by Application
    5.1 Global Autologous Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Autologous Cell Therapy Market Size (2017-2028)
    6.2 North America Autologous Cell Therapy Market Size by Type
        6.2.1 North America Autologous Cell Therapy Market Size by Type (2017-2022)
        6.2.2 North America Autologous Cell Therapy Market Size by Type (2023-2028)
        6.2.3 North America Autologous Cell Therapy Market Share by Type (2017-2028)
    6.3 North America Autologous Cell Therapy Market Size by Application
        6.3.1 North America Autologous Cell Therapy Market Size by Application (2017-2022)
        6.3.2 North America Autologous Cell Therapy Market Size by Application (2023-2028)
        6.3.3 North America Autologous Cell Therapy Market Share by Application (2017-2028)
    6.4 North America Autologous Cell Therapy Market Size by Country
        6.4.1 North America Autologous Cell Therapy Market Size by Country (2017-2022)
        6.4.2 North America Autologous Cell Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Autologous Cell Therapy Market Size (2017-2028)
    7.2 Europe Autologous Cell Therapy Market Size by Type
        7.2.1 Europe Autologous Cell Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Autologous Cell Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Autologous Cell Therapy Market Share by Type (2017-2028)
    7.3 Europe Autologous Cell Therapy Market Size by Application
        7.3.1 Europe Autologous Cell Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Autologous Cell Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Autologous Cell Therapy Market Share by Application (2017-2028)
    7.4 Europe Autologous Cell Therapy Market Size by Country
        7.4.1 Europe Autologous Cell Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Autologous Cell Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Autologous Cell Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Autologous Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific Autologous Cell Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Autologous Cell Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Autologous Cell Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Autologous Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific Autologous Cell Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Autologous Cell Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Autologous Cell Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Autologous Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific Autologous Cell Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Autologous Cell Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Autologous Cell Therapy Market Size (2017-2028)
    9.2 Latin America Autologous Cell Therapy Market Size by Type
        9.2.1 Latin America Autologous Cell Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Autologous Cell Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Autologous Cell Therapy Market Share by Type (2017-2028)
    9.3 Latin America Autologous Cell Therapy Market Size by Application
        9.3.1 Latin America Autologous Cell Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Autologous Cell Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Autologous Cell Therapy Market Share by Application (2017-2028)
    9.4 Latin America Autologous Cell Therapy Market Size by Country
        9.4.1 Latin America Autologous Cell Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Autologous Cell Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Autologous Cell Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Autologous Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa Autologous Cell Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Autologous Cell Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Autologous Cell Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Autologous Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa Autologous Cell Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Autologous Cell Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Autologous Cell Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Autologous Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa Autologous Cell Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Autologous Cell Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 BioTime
        11.1.1 BioTime Company Details
        11.1.2 BioTime Business Overview
        11.1.3 BioTime Autologous Cell Therapy Introduction
        11.1.4 BioTime Revenue in Autologous Cell Therapy Business (2017-2022)
        11.1.5 BioTime Recent Developments
    11.2 Pharmicell
        11.2.1 Pharmicell Company Details
        11.2.2 Pharmicell Business Overview
        11.2.3 Pharmicell Autologous Cell Therapy Introduction
        11.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2017-2022)
        11.2.5 Pharmicell Recent Developments
    11.3 BrainStorm Cell Therapeutics
        11.3.1 BrainStorm Cell Therapeutics Company Details
        11.3.2 BrainStorm Cell Therapeutics Business Overview
        11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
        11.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2017-2022)
        11.3.5 BrainStorm Cell Therapeutics Recent Developments
    11.4 Opexa Therapeutics
        11.4.1 Opexa Therapeutics Company Details
        11.4.2 Opexa Therapeutics Business Overview
        11.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
        11.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2017-2022)
        11.4.5 Opexa Therapeutics Recent Developments
    11.5 Vericel Corporation
        11.5.1 Vericel Corporation Company Details
        11.5.2 Vericel Corporation Business Overview
        11.5.3 Vericel Corporation Autologous Cell Therapy Introduction
        11.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2017-2022)
        11.5.5 Vericel Corporation Recent Developments
    11.6 Regeneus
        11.6.1 Regeneus Company Details
        11.6.2 Regeneus Business Overview
        11.6.3 Regeneus Autologous Cell Therapy Introduction
        11.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2017-2022)
        11.6.5 Regeneus Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Bone Marrow
    Table 3. Key Players of Epidermis
    Table 4. Global Autologous Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Autologous Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Autologous Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Autologous Cell Therapy Market Share by Region (2017-2022)
    Table 8. Global Autologous Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Autologous Cell Therapy Market Share by Region (2023-2028)
    Table 10. Autologous Cell Therapy Market Trends
    Table 11. Autologous Cell Therapy Market Drivers
    Table 12. Autologous Cell Therapy Market Challenges
    Table 13. Autologous Cell Therapy Market Restraints
    Table 14. Global Autologous Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Autologous Cell Therapy Revenue Share by Players (2017-2022)
    Table 16. Global Top Autologous Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2021)
    Table 17. Ranking of Global Top Autologous Cell Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Autologous Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Autologous Cell Therapy Product Solution and Service
    Table 21. Date of Enter into Autologous Cell Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Autologous Cell Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Autologous Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Autologous Cell Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Autologous Cell Therapy Revenue Share by Application (2017-2022)
    Table 29. Global Autologous Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Autologous Cell Therapy Revenue Share by Application (2023-2028)
    Table 31. North America Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Autologous Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Autologous Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Autologous Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Autologous Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Autologous Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Autologous Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Autologous Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Autologous Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Autologous Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Autologous Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Autologous Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Autologous Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Autologous Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Autologous Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Autologous Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Autologous Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Autologous Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Autologous Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Autologous Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Autologous Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Autologous Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Autologous Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. BioTime Company Details
    Table 62. BioTime Business Overview
    Table 63. BioTime Autologous Cell Therapy Product
    Table 64. BioTime Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 65. BioTime Recent Developments
    Table 66. Pharmicell Company Details
    Table 67. Pharmicell Business Overview
    Table 68. Pharmicell Autologous Cell Therapy Product
    Table 69. Pharmicell Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 70. Pharmicell Recent Developments
    Table 71. BrainStorm Cell Therapeutics Company Details
    Table 72. BrainStorm Cell Therapeutics Business Overview
    Table 73. BrainStorm Cell Therapeutics Autologous Cell Therapy Product
    Table 74. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 75. BrainStorm Cell Therapeutics Recent Developments
    Table 76. Opexa Therapeutics Company Details
    Table 77. Opexa Therapeutics Business Overview
    Table 78. Opexa Therapeutics Autologous Cell Therapy Product
    Table 79. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 80. Opexa Therapeutics Recent Developments
    Table 81. Vericel Corporation Company Details
    Table 82. Vericel Corporation Business Overview
    Table 83. Vericel Corporation Autologous Cell Therapy Product
    Table 84. Vericel Corporation Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 85. Vericel Corporation Recent Developments
    Table 86. Regeneus Company Details
    Table 87. Regeneus Business Overview
    Table 88. Regeneus Autologous Cell Therapy Product
    Table 89. Regeneus Revenue in Autologous Cell Therapy Business (2017-2022) & (US$ Million)
    Table 90. Regeneus Recent Developments
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Autologous Cell Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Bone Marrow Features
    Figure 3. Epidermis Features
    Figure 4. Global Autologous Cell Therapy Market Share by Application: 2021 VS 2028
    Figure 5. Neurology Case Studies
    Figure 6. Orthopedics Case Studies
    Figure 7. Cancer Case Studies
    Figure 8. Wound Healing Case Studies
    Figure 9. Other Case Studies
    Figure 10. Autologous Cell Therapy Report Years Considered
    Figure 11. Global Autologous Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Autologous Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Autologous Cell Therapy Market Share by Region: 2021 VS 2028
    Figure 14. Global Autologous Cell Therapy Market Share by Players in 2021
    Figure 15. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2021
    Figure 17. North America Autologous Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Autologous Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 19. North America Autologous Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 20. North America Autologous Cell Therapy Market Size Share by Country (2017-2028)
    Figure 21. United States Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Autologous Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Autologous Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Autologous Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Autologous Cell Therapy Market Size Share by Country (2017-2028)
    Figure 27. Germany Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Autologous Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Autologous Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Autologous Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Autologous Cell Therapy Market Size Share by Region (2017-2028)
    Figure 37. China Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Autologous Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Autologous Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Autologous Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Autologous Cell Therapy Market Size Share by Country (2017-2028)
    Figure 47. Mexico Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Autologous Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Autologous Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Autologous Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Autologous Cell Therapy Market Size Share by Country (2017-2028)
    Figure 53. Turkey Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Autologous Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 57. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 58. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 59. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 60. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 61. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed